This review systematically analyzes key challenges in DDI prediction: balancing model performance with interpretability, integrating heterogeneous features, ensuring sample set reliability, and optimizing algorithmic architectures, and outlines promising directions for future innovation.
Abstract
Drug–Drug Interaction (DDI) prediction is pivotal in pharmaceutical research
and clinical practice, enhancing medication safety and optimizing therapeutic strategies. Traditional
experimental approaches, constrained by high costs and time consumption, are insufficient for
large-scale screening. Consequently, computational prediction methods have garnered increasing attention.
This review systematically analyzes key challenges in DDI prediction: balancing model
performance with interpretability, integrating heterogeneous features, ensuring sample set reliability,
and optimizing algorithmic architectures. Database resources are categorized into drug interaction databases
(e.g., DrugBank), compound feature databases (e.g., PubChem), and protein-related databases
(e.g., UniProt).
Four primary feature encoding strategies are examined: pre-trained language model representations,
multimodal fusion encoding, chemical structure-based encoding, and knowledge graphbased
encoding. Mainstream DDI prediction approaches are classified into five paradigms: traditional
machine learning, deep learning, graph neural networks, knowledge graph-based methods, and contrastive
learning approaches.
Empirical results from benchmark datasets demonstrate that deep learning models integrating
multi-scale features and attention mechanisms (e.g., MSDF) achieve superior predictive accuracy,
while graph neural networks (e.g., GCN-BMP) excel at capturing complex relational structures.
This review provides a robust reference for methodological selection and outlines promising
directions for future innovation in DDI prediction, offering valuable guidance for advancing
drug safety evaluation in precision medicine.
Two deep learning-based computational protocols designed to address drug mechanisms of action and predicting drug-target interactions are presented, offering scalable, cost-effective tools for accelerating therapeutic development by bridging chemical structure, molecular interactions, and systems-level biological respo...
Y. Sun, Cheng-You Liu, Zi-Hao Jing et al.· Methods in molecular biology· 0 citations
A paradigm shift toward autonomous scientific agents capable of causal reasoning and end-to-end experimental guidance is highlighted, and persistent challenges are discussed, including data bias, limited interpretability, and in silico-to-wet lab translation.
The current application status of artificial intelligence in DDI prediction can promote existing pharmacological theories and provide practical references for clinical medication, which can promote existing pharmacological theories and provide practical references for clinical medication.
Jun-Ru Lu· Proceedings of the 4th Inter...· 0 citations
A claim-centered framework is introduced that clarifies which claims current DDI benchmarks can support and what additional evidence is needed before predictions can guide prescribing or monitoring and shows that useful explanations require evidence alignment and actionability in addition to visual plausibility.
Jing-Xiang Yang· Computers and artificial int...· 0 citations
This review systematically summarizes the latest research progress in druggable protein prediction algorithms, providing a comprehensive analysis across three dimensions: data resources, feature engineering, and predictive models.
Hong-Qi Zhang, Hong-Ling Wang, Shang-Hua Liu et al.· Current Drug Targets· 0 citations
Artificial intelligence-driven ADMET prediction is becoming a vital tool in lowering attrition, speeding up candidate prioritization, and influencing the direction of rational drug development, despite persistent issues with data quality, regulatory acceptance, and synthetic viability.
Satyam Kumar Vishwash, Ram Babu Soni, Ratima Sood et al.· Current Computer - Aided Dru...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.